Hsu-Feng Lu

467 total citations
16 papers, 410 citations indexed

About

Hsu-Feng Lu is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Hsu-Feng Lu has authored 16 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Pharmacology and 3 papers in Complementary and alternative medicine. Recurrent topics in Hsu-Feng Lu's work include Natural product bioactivities and synthesis (5 papers), Fungal Biology and Applications (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Hsu-Feng Lu is often cited by papers focused on Natural product bioactivities and synthesis (5 papers), Fungal Biology and Applications (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Hsu-Feng Lu collaborates with scholars based in Taiwan. Hsu-Feng Lu's co-authors include Jing‐Gung Chung, Jai‐Sing Yang, Tzu-Wei Tan, Mei‐Fen Tsou, Nou-Ying Tang, Nai-Wen Chang, Te-Mao Li, Yung‐Liang Chen, Chin-Chung Lin and Ming‐Fang Wu and has published in prestigious journals such as Frontiers in Pharmacology, Molecular Medicine Reports and BMC Complementary Medicine and Therapies.

In The Last Decade

Hsu-Feng Lu

16 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsu-Feng Lu Taiwan 12 230 118 72 66 59 16 410
Chao-Ying Lee Taiwan 8 313 1.4× 81 0.7× 74 1.0× 74 1.1× 67 1.1× 10 585
Chun Shu Yu Taiwan 12 275 1.2× 157 1.3× 49 0.7× 92 1.4× 58 1.0× 20 518
Mei‐Fen Tsou Taiwan 8 249 1.1× 85 0.7× 110 1.5× 62 0.9× 63 1.1× 10 480
François Gaascht Luxembourg 13 298 1.3× 217 1.8× 98 1.4× 90 1.4× 36 0.6× 14 623
M Sreepriya India 12 201 0.9× 75 0.6× 77 1.1× 90 1.4× 104 1.8× 23 526
Matthew Iyobhebhe Nigeria 11 155 0.7× 62 0.5× 52 0.7× 84 1.3× 50 0.8× 31 480
Zongping Zhu China 11 283 1.2× 51 0.4× 62 0.9× 114 1.7× 64 1.1× 17 562
Riris Istighfari Jenie Indonesia 15 320 1.4× 174 1.5× 76 1.1× 117 1.8× 63 1.1× 88 692
Yi‐Shih Ma Taiwan 15 321 1.4× 106 0.9× 32 0.4× 119 1.8× 48 0.8× 24 565
Dharam Chand Attri India 6 221 1.0× 69 0.6× 24 0.3× 93 1.4× 59 1.0× 20 449

Countries citing papers authored by Hsu-Feng Lu

Since Specialization
Citations

This map shows the geographic impact of Hsu-Feng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsu-Feng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsu-Feng Lu more than expected).

Fields of papers citing papers by Hsu-Feng Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsu-Feng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsu-Feng Lu. The network helps show where Hsu-Feng Lu may publish in the future.

Co-authorship network of co-authors of Hsu-Feng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Hsu-Feng Lu. A scholar is included among the top collaborators of Hsu-Feng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsu-Feng Lu. Hsu-Feng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lu, Hsu-Feng, et al.. (2021). Ugonin J Acts as a SARS-CoV-2 3C-like Protease Inhibitor and Exhibits Anti-inflammatory Properties. Frontiers in Pharmacology. 12. 720018–720018. 11 indexed citations
2.
Lin, Yu-Chun, et al.. (2020). Purple-leaf tea (Camellia sinensis L.) ameliorates high-fat diet induced obesity and metabolic disorder through the modulation of the gut microbiota in mice. BMC Complementary Medicine and Therapies. 20(1). 376–376. 26 indexed citations
3.
Lin, Jen‐Jyh, Kung-Wen Lu, Nou-Ying Tang, et al.. (2015). Alpha-phellandrene, a natural active monoterpene, influences a murine WEHI-3 leukemia model in vivo by enhancing macrophague phagocytosis and natural killer cell activity.. PubMed. 28(4). 583–8. 22 indexed citations
4.
Wu, Ming‐Fang, et al.. (2014). Toxicological evaluation of Antrodia cinnamomea in BALB/c mice.. PubMed. 27(6). 739–45. 16 indexed citations
5.
Yeh, Ming‐Yang, et al.. (2013). Effects of chitosan on xenograft models of melanoma in C57BL/6 mice and hepatoma formation in SCID mice.. PubMed. 33(11). 4867–73. 12 indexed citations
6.
Lu, Hsu-Feng, et al.. (2012). Evaluation of genotoxicity and subclinical toxicity of Agaricus blazei Murrill in the Ames test and in histopathological and biochemical analysis.. PubMed. 26(3). 437–45. 5 indexed citations
7.
Wu, Ming‐Fang, et al.. (2012). Carbon tetrachloride-induced hepatotoxicity and its amelioration by Agaricus blazei Murrill extract in a mouse model.. PubMed. 25(6). 971–6. 9 indexed citations
8.
Chen, Yung‐Liang, Hsu-Feng Lu, Jai‐Sing Yang, et al.. (2011). Danthron inhibits murine WEHI-3 cells in vivo, and enhances macrophage phagocytosis and natural killer cell cytotoxic activity in leukemic mice.. PubMed. 25(3). 393–8. 8 indexed citations
9.
Lu, Hsu-Feng. (2011). Feasibility study for epidemic prevention and control in a regional hospital. Molecular Medicine Reports. 5(3). 859–65. 6 indexed citations
10.
Wu, Ming‐Fang, Yung‐Liang Chen, Yu‐Ming Hsu, et al.. (2011). Effect of Agaricus blazei Murrill extract on HT-29 human colon cancer cells in SCID mice in vivo.. PubMed. 25(4). 673–7. 15 indexed citations
11.
Yang, Jai‐Sing, et al.. (2008). Curcumin inhibits WEHI-3 leukemia cells in BALB/c mice in vivo.. PubMed. 22(1). 63–8. 28 indexed citations
12.
Lu, Hsu-Feng, et al.. (2008). Coumarin induces cell cycle arrest and apoptosis in human cervical cancer HeLa cells through a mitochondria- and caspase-3 dependent mechanism and NF-kappaB down-regulation.. PubMed. 21(6). 1003–9. 56 indexed citations
13.
Yang, Jai‐Sing, et al.. (2008). Baicalein induces apoptosis in SCC-4 human tongue cancer cells via a Ca2+-dependent mitochondrial pathway.. PubMed. 21(6). 1053–8. 51 indexed citations
14.
Yang, Jai‐Sing, et al.. (2007). Berberine inhibits WEHI-3 leukemia cells in vivo.. PubMed. 21(2). 407–12. 38 indexed citations
15.
Tan, Tzu-Wei, et al.. (2007). Curcumin-induced cell cycle arrest and apoptosis in human acute promyelocytic leukemia HL-60 cells via MMP changes and caspase-3 activation.. PubMed. 26(6B). 4361–71. 88 indexed citations
16.
Lu, Hsu-Feng, et al.. (2005). (-)-Menthol inhibits DNA topoisomerases I, II alpha and beta and promotes NF-kappaB expression in human gastric cancer SNU-5 cells.. PubMed. 25(3B). 2069–74. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026